Benefits
Short-term muscle protein synthesis (related ingredient, 10 people)
No published trial of MyoVera has tested this. The closest evidence is a study of a related amylopectin and chromium complex in ten adults (6 men, 4 women) who took 6 grams of whey protein with or without 2 grams of the complex. Muscle protein synthesis measured over the following hours was higher when the complex was added (difference between conditions p = 0.045). Muscle protein synthesis over a few hours is a laboratory measurement, not a measured gain in muscle size or strength, and ten people is a very small study.
Enhanced amino acid muscle uptake
This is the proposed mechanism, not a measured result. Chromium is involved in insulin signaling, and insulin helps move amino acids into muscle cells. No published study has measured amino acid uptake in people taking MyoVera.
Age-related muscle loss (not studied)
Adults commonly lose muscle as they age, and staying active with enough protein helps. MyoVera has not been tested in older adults, or in anyone else, in any published study. It has not been shown to prevent, slow, or treat sarcopenia or any other condition, and it has not been shown to maintain strength or performance.
Supports inadequate protein intake populations
Many older adults do fall short on protein, which matters for keeping muscle. Whether MyoVera changes anything for people eating less protein has never been tested. The one small human study of the related amylopectin and chromium complex gave 6 grams of whey protein to ten adults and measured only a few hours of muscle protein synthesis, so it says nothing about people with low protein intake over time.
Evidence base: nothing published on MyoVera
This page cites no studies at all, and no trial of MyoVera appears in the published literature. The claim of two clinical studies comes from the manufacturer's marketing. Without published papers there is no way to check who was studied, at what dose, for how long, or what was actually measured.
Predecessor ingredient research (rat study)
The study behind this claim was done in rats, not people: adding the amylopectin and chromium complex to branched-chain amino acids raised muscle protein synthesis and mTOR signaling compared with the amino acids alone. Animal results do not transfer to humans on their own, and MyoVera is a different product from the complex that was tested. There is no evidence that any of this 'translates' to MyoVera.
Strength and performance (never measured)
No published study has measured muscle size, strength, or physical performance with MyoVera. The single small human study of the related complex measured only short-term muscle protein synthesis in ten people, which does not tell you whether anyone became bigger, stronger, or faster.
Insulin signaling (proposed mechanism only)
Chromium is involved in insulin signaling, and insulin helps push amino acids into muscle cells. The claim that two chromium forms work better together than one has not been tested in any published study, in people or in animals.
Mechanism of action
Insulin-mediated amino acid uptake
Chromium plays a role in insulin signaling, and insulin helps drive amino acids into muscle cells. That is the theory behind MyoVera. It has not been confirmed in any published study of the product itself.
mTOR pathway activation enhancement
In a study in rats, adding the amylopectin and chromium complex to branched-chain amino acids increased mTOR signaling, a pathway that helps switch on muscle protein synthesis. This was an animal study of a different, earlier ingredient, and it did not measure muscle growth in anyone.
Insulin sensitivity (untested for this product)
Chromium has been studied for a role in insulin sensitivity. Whether MyoVera's two chromium forms change insulin sensitivity, and whether that would change anything about muscle, has not been tested in any published study.
Muscle protein synthesis amplification
The proposed idea is that MyoVera makes the body's muscle protein synthesis response to protein and exercise larger. No published trial of MyoVera has measured this. In the one human study of the related complex, ten adults showed a higher short-term muscle protein synthesis rate when 2 grams of the complex were added to 6 grams of whey protein.
Dual-chromium synergy
Different chromium forms are absorbed differently. The claim that combining two forms works better than one is the manufacturer's rationale for its patent, not a finding from any published head-to-head comparison.
Clinical trials
No trial of MyoVera has been published. The manufacturer refers to two clinical studies, but no paper, dose, sample size, duration, or result is available for anyone to check.
Unknown. No published paper describes who, if anyone, was studied.
There are no findings to report. These are manufacturer statements, not published results, and 'two-study replication' cannot be verified. The only human data on a related ingredient come from a ten-person crossover study of an amylopectin and chromium complex, which found a higher short-term muscle protein synthesis rate when 2 grams were added to 6 grams of whey protein (between-condition p = 0.045). That study did not test MyoVera and did not measure muscle size or strength.
Animal study, not a clinical trial: 24 male rats (8 per group) given exercise alone, exercise plus branched-chain amino acids, or exercise plus those amino acids and the amylopectin/chromium complex. It tested the earlier complex, not MyoVera, and results in rats do not establish anything for people.
24 male rats in three groups. No people took part in this study.
In the rats, adding the amylopectin/chromium complex to branched-chain amino acids raised muscle protein synthesis, insulin, and mTOR signaling compared with the amino acids alone. That is a mechanism result in animals. It does not show that MyoVera, or the complex, builds muscle in people.
General background reading on age-related muscle loss, including observational research linking muscle mass to health outcomes. Observational links show association, not cause. None of this background tested MyoVera or any chromium product.
General populations in background research. Nobody in it took MyoVera.
These are commonly quoted background figures on muscle loss and protein intake as people age. They describe a general problem and say nothing about MyoVera. No study has shown that MyoVera makes protein more effective, in older adults or in anyone else.